ARCH Venture Partners XII, LLC, 10% Owner at Neumora Therapeutics, Inc. (NMRA), bought 161,196 shares at $11.55 ($1.9M) on 2023-11-06, disclosed to the SEC on 2023-11-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.38 | 22,420 | $255K | 13.8% |
| 2 | $11.38 | 22,420 | $255K | 13.8% |
| 3 | $11.55 | 43,082 | $498K | 26.9% |
| 4 | $11.55 | 43,082 | $498K | 26.9% |
| 5 | $11.50 | 30,192 | $347K | 18.7% |
| Total | $11.49 avg | 161,196 |
| $1.9M |
| 100% |
| Filing → |
| PRME | BUY | 2024-02-20 | $20.0M | — | Filing → |